XML 41 R10.htm IDEA: XBRL DOCUMENT
v3.23.2

Intangible Assets, Net | 6 Months Ended
--- | ---
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets, Net | Intangible Assets, Net At June 30, 2023, the Company’s intangible assets, net, consisted of the following (in thousands):
| Useful Life (Years) |  | Gross June 30, 2023 |  | Accumulated Amortization |  | Net June 30, 2023
Indefinite lived assets: |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | (100,244) |  |  | 50,435 |
Management contracts | 15 |  | 22,832 |  |  | (15,982) |  |  | 6,850 |
Member relationships | 10-14 |  | 20,477 |  |  | (6,302) |  |  | 14,175 |
Patient management platform | 5 |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | (282) |  |  | 729 |
Developed technology | 6 |  | 107 |  |  | (25) |  |  | 82 |
|  |  | $ | 199,316 |  |  | $ | (124,895) |  |  | $ | 74,421 |
At December 31, 2022, the Company’s intangible assets, net, consisted of the following (in thousands):
| Useful Life (Years) |  | Gross December 31, 2022 |  | Accumulated Amortization |  | Net December 31, 2022
Indefinite lived assets: |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | (95,451) |  |  | 55,228 |
Management contracts | 15 |  | 22,832 |  |  | (15,208) |  |  | 7,624 |
Member relationships | 12 |  | 16,633 |  |  | (5,619) |  |  | 11,014 |
Patient management platform | 5 |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | (257) |  |  | 754 |
Developed technology | 6 |  | 107 |  |  | (16) |  |  | 91 |
|  |  | $ | 195,472 |  |  | $ | (118,611) |  |  | $ | 76,861 |
For the three months ended June 30, 2023 and 2022, the Company recognized amortization expense of $3.3 million and $3.5 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations. For the six months ended June 30, 2023 and 2022, the Company recognized amortization expense of $6.3 million and $7.2 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations. The Company determined that there was no impairment of its finite-lived intangible or long-lived assets during the during the six months ended June 30, 2023 and 2022. Future amortization expense is estimated to be as follows for the following years ending December 31 (in thousands):
| Amount
2023 (excluding the six months ended June 30, 2023) | $ | 6,157 |
2024 | 12,249 |
2025 | 11,171 |
2026 | 9,811 |
2027 | 8,430 |
Thereafter | 24,453 |
Total | $ | 72,271 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350-30/tableOfContent + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration